Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine for inpatients with borderline personality disorder
2018-002471-18Phase 4Unknown
- Sponsor
- Imperial College London
- Start
- Jun 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in borderline personality disorder (BPD) comparing Clozaril + usual care with Placebo + usual care (2 arms). Primary endpoint: ZAN-BPD total score at six months. Status: unknown.
02
Drugs
clozapine
03
Conditions
borderline personality disorder (BPD)
Beyond the preview
Go deeper on 2018-002471-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002471-18.